Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.86 |
| ▸ | CNR1 | P21554 | 13/20 | 0.86 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.78 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.78 |
| ▸ | FAAH | O00519 | 2/20 | 0.78 |
| ▸ | DRD3 | P35462 | 2/20 | 0.78 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.78 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.78 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.78 |
| ▸ | LDHA | P00338 | 1/20 | 0.78 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.78 |
| ▸ | GPR183 | P32249 | 1/20 | 0.78 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.78 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.66 |
| ▸ | HTR1A | P08908 | 1/20 | 0.66 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.66 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23415525 | 1.00 | CNR2 (0.86) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL21363770 | 1.00 | CNR2 (0.86) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL31546115 | 1.00 | CNR2 (0.86) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL20763968 | 1.00 | CNR2 (0.86) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL31545117 | 0.93 | CNR2 (0.78) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL22095410 | 0.93 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL20763972 | 0.93 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL31544994 | 0.93 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL21363560 | 0.93 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH | |
| SCHEMBL31544941 | 0.93 | CNR2 (1.00) | CNR2CNR1ABHD12ABHD6FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083361-A1 | NON-INVASIVE DETERMINATION OF A PHYSIOLOGICAL STATE OF INTEREST IN A SUBJECT | ISBRG CORP (CA) | 2026-03-26 | — | — | US | claimed |
| EP-4486336-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119136797-A | CB1Ligand conjugated compounds and uses thereof | 阿达尔克斯制药有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-11918352-B2 | Non-invasive determination of a physiological state of interest in a subject | ISBRG CORP. (CA) | 2024-03-05 | — | — | US | claimed |
| WO-2023168296-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | ADARX PHARMACEUTICALS, INC. (US) | 2023-09-07 | — | — | WO | claimed |
| US-11686722-B2 | Compositions and methods to detect molecules in a sample | INFUSENSE CORP. (US) | 2023-06-27 | — | — | US | claimed |
| US-20220211299-A1 | NON-INVASIVE DETERMINATION OF A PHYSIOLOGICAL STATE OF INTEREST IN A SUBJECT | ISBRG CORP. (CA) | 2022-07-07 | — | — | US | claimed |
| US-20190331656-A1 | COMPOSITIONS AND METHODS TO DETECT MOLECULES IN A SAMPLE | INFUSENSE CORP. | 2019-10-31 | — | — | US | claimed |
| US-20260138132-A1 | AMBIENT CONTAMINATION IN BREATH ANALYTE DETECTION AND MEASUREMENT | HOUND LABS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12622920-B2 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | PICO IP, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | NATURAL EXTRACTION SYS LLC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260083361-A1 | NON-INVASIVE DETERMINATION OF A PHYSIOLOGICAL STATE OF INTEREST IN A SUBJECT | ISBRG CORP (CA) | 2026-03-26 | — | — | US | disclosed |
| US-20260076921-A1 | Transdermal Pharmaceutical Formulations for the Treatment of Multiple Sclerosis | PIKE THERAPEUTICS INC (CA) | 2026-03-19 | — | — | US | disclosed |
| US-12569504-B2 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | Terry, Miles J. | 2026-03-10 | — | — | US | disclosed |
| US-7465586-B2 | Oral detection test for cannabinoid use | LABONE, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-7465586-B2 | Oral detection test for cannabinoid use | LABONE, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-7465586-B2 | Oral detection test for cannabinoid use | LABONE, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-20080194041-A1 | INTEGRATED DEVICE FOR ANALYTE, TESTING, CONFIRMATION, AND DONOR IDENTITY VERIFICATION | LUDWIG & ROBINSON PLLC | 2008-08-14 | — | — | US | disclosed |
| US-20060094123-A1 | Oral detection test for cannabinoid use | LABONE, INC. | 2006-05-04 | — | — | US | disclosed |
| US-20040018151-A1 | Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods | ABOOD MARY E (US) | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083361-A1 | NON-INVASIVE DETERMINATION OF A PHYSIOLOGICAL STATE OF INTEREST IN A SUBJECT | CNR1, CNR2, OGFR | CNR2 2/4885CNR1 1/4885ABHD12 2278/4885 |
| US-12569504-B2 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | CNR1, CNR2, TMEM97 | CNR2 2/4885CNR1 1/4885ABHD12 1961/4885 |
| US-20260076921-A1 | Transdermal Pharmaceutical Formulations for the Treatment of Multiple Sclerosis | SOST, CNR2, BHMT2 | CNR2 2/4885CNR1 25/4885ABHD12 3388/4885 |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | CNR2, CNR1, OPRD1 | CNR2 1/4885CNR1 2/4885ABHD12 750/4885 |
| US-12622920-B2 | Process for creating a cannabinoid pico-emulsion with antibiotic properties and the resulting pico-emulsion | CNR1, CNR2, NPC1L1 | CNR2 2/4885CNR1 1/4885ABHD12 2480/4885 |
| US-20260138132-A1 | AMBIENT CONTAMINATION IN BREATH ANALYTE DETECTION AND MEASUREMENT | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885ABHD12 115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.